Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Cipher Pharmaceuticals Inc. T.CPH

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  CPHMF | CPHR

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with three commercial products and fourth in development, which are improved formulations of marketed drugs.
Price: $17.64 | Change: +$0.01 | %Change: +0.06%
Volume: 14,697 | Day High/Low: 17.74/17.15 | 52 Week High/Low: 19.52/6.75
View modes: 
0 stars

RE:RE:wall of shares on the ask at $17.50... eom

it's weird that someone would place so many shares for sell all at once at $17.50 on such a strong day as today. If they would just wait the price would go up and have more momentum so that they could...read more
1 star

RE:wall of shares on the ask at $17.50... eom

The joys of a small cap.. I'll assume thats the same person who was trying to sell at 18, and didnt get it.. then the block moved into the 17.60s now at 17.50..  On the plus side that block is down...read more
0 stars

wall of shares on the ask at $17.50... eom

50,900....hasn't even been dented  rate and reply
3.5 stars

C$ down to 0.80 US, a 20 % boost to Absorbica profits!!

The more the C$ drops the better for Cipher profits. Look for the C$ to go down to 0.75 cents US. When Cipher brings those USA dollars back to Canada we all win.  rate and reply
5 stars

RE:Cipher Pharmaceuticals appoints Lynne Bulger as Vice Preside

Very good news. I wish one of my other pharmas had someone in that same role.  rate and reply
5 stars

Cipher Pharmaceuticals appoints Lynne Bulger as Vice Preside

MISSISSAUGA, ON, Jan. 19, 2015 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced the appointment of Lynne Bulger as Vice President, Medical and...read more
5 stars

RE:donville prediction

It was his top pick on Oct 24th 2014 when it was at $11.60.  The last time he was on, he was asked about Cipher and stated that he preferred Biosyent as Cipher was fully valued (at $18.56).  It has...read more
4.5 stars

donville prediction

Greetings, I would not be surprised to see Jason Donville recommend CPH as a top pick on BNN next time he is on the show. With the wonderful ROE , ROA and profit margins, and no debt,  with valuable...read more
3 stars

Bruce Campbell 2 Holding

Second half of the clip. Was asked about MSL vs CRH but at the end of the question, he indicated that he held two stocks in the sector - CPH and CXR. GLTA http://www.bnn.ca/Video/player.aspx?vid...read more
5 stars

RE:RE:Techie 07 member since January 09 2014 is styless again

just stop it, when Chipher gives its January presentation your answers will be given whether patent challenge latest aquisitions and future plans. Both of you can read last years presentation here...read more
5 stars

RE:Techie 07 member since January 09 2014 is styless again

The success rate in overturning such patents is less the 0.01 %  and Cipher has 2 patents not 1. A settlement is not a success it is an agreed upon outcome styless, both sides win.   This issue has...read more
3 stars

RE:RE:RE:RE:RE:RE:RE:RE:Cipher Pharmaceuticals acquires assets of Melanovus Oncology

To be clear I also think management is going a great job and based on signing two deals in the first week of 2015 I expect there will be many more deals in the coming weeks and months.  rate and reply
3.5 stars

RE:Techie 07 member since January 09 2014 is styless again

wow looks like I hit a nerve! Speaking of pumping the stock, where exactly did you read or hear about the 99.9 % chance of success? Formulation patents on reformulated products are by nature...read more
5 stars

Techie 07 member since January 09 2014 is styless again

Again with another new ID and on again about the litigation stupidless liar! The 99.999%  certain outcome is known. Shaving of perhaps 6 months off of the Absorbica patent in 2021 in an agreed...read more
2.5 stars

RE:RE:RE:RE:RE:RE:RE:RE:Cipher Pharmaceuticals acquires assets of Melanovus Oncology

with one of their three current products coming off patent sometime in January and their largest product facing patent litigation in the next few months, where would you be investing your time and...read more
3 stars

RE:RE:RE:RE:RE:RE:RE:Cipher Pharmaceuticals acquires assets of Melanovus Oncology

Well, I have a different view about the aquisition.  Of course, Cipher shareholders are attracted by profit, growing revenues and cast flow. I would point out that the company already has an 85% ROE...read more
3 stars

RE:RE:RE:RE:RE:RE:Cipher Pharmaceuticals acquires assets of Melanovus Oncology

Correct me if I'm wrong but Cipher shareholders I think are attracted to profit, growing revenues and cash flow. This acquisition simply does not fit with those goals. These assets will not attract...read more
5 stars

Who says Cipher is finished its acquisitions??

Cipher has only spent 500k. Cipher is showing they don't waste money like the US government does. Cipher is frugal, I like it. I bet Cipher will make more big impact acquisitions, when the price is...read more
0 stars

Chewed Through 25,000 at $17

Next stop 50,000 at $18.00.  Setting a good base.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:Cipher Pharmaceuticals acquires assets of Melanovus Oncology

Well said, ValueCat.  rate and reply